A Factor Model to Analyze Heterogeneity in Gene Expression BMC Bioinformatics 2010, 11:368

Total Page:16

File Type:pdf, Size:1020Kb

A Factor Model to Analyze Heterogeneity in Gene Expression BMC Bioinformatics 2010, 11:368 Blum et al. BMC Bioinformatics 2010, 11:368 http://www.biomedcentral.com/1471-2105/11/368 METHODOLOGY ARTICLE Open Access AMethodology factor article model to analyze heterogeneity in gene expression Yuna Blum*1,2,3, Guillaume Le Mignon1,2, Sandrine Lagarrigue1,2 and David Causeur3 Abstract Background: Microarray technology allows the simultaneous analysis of thousands of genes within a single experiment. Significance analyses of transcriptomic data ignore the gene dependence structure. This leads to correlation among test statistics which affects a strong control of the false discovery proportion. A recent method called FAMT allows capturing the gene dependence into factors in order to improve high-dimensional multiple testing procedures. In the subsequent analyses aiming at a functional characterization of the differentially expressed genes, our study shows how these factors can be used both to identify the components of expression heterogeneity and to give more insight into the underlying biological processes. Results: The use of factors to characterize simple patterns of heterogeneity is first demonstrated on illustrative gene expression data sets. An expression data set primarily generated to map QTL for fatness in chickens is then analyzed. Contrarily to the analysis based on the raw data, a relevant functional information about a QTL region is revealed by factor-adjustment of the gene expressions. Additionally, the interpretation of the independent factors regarding known information about both experimental design and genes shows that some factors may have different and complex origins. Conclusions: As biological information and technological biases are identified in what was before simply considered as statistical noise, analyzing heterogeneity in gene expression yields a new point of view on transcriptomic data. Background Recently, several works have introduced models for the Microarray technology allows the analysis of expression common information shared by all the genes. Especially levels for thousands of genes simultaneously and is a Friguet et al [4] propose to model this sharing of informa- powerful tool to characterize mRNA level variation due tion by a factor analysis structure in a method called Fac- to measured variables of interest (various phenotypes, tor Analysis for Multiple Testing (FAMT). The estimated treatments...). Typical approaches to find significant rela- factors in the model capture components of the expres- tionships between gene expressions and experimental sion heterogeneity. As well, Storey et al [3] introduce Sur- conditions ignore the correlations among expression pro- rogate Variable Analysis (SVA) to identify and estimate files and functional categories [1]. This dependence these extra sources of variation. The factors in FAMT and structure leads to correlation among test statistics which the surrogate variables in SVA are similarly designed to affects a strong control of the actual proportion of false model dependence among tests by a linear kernel but discoveries [2]. Indeed, a number of unmeasured or they are estimated differently. Contrarily to the SVA unmodeled factors independent of the variables of inter- model, independence between the factors and the experi- est may influence the expression of any particular gene mental conditions of interest is explicitly assumed in [3,4]. These factors may induce extra variability in the FAMT in order to separate clearly the effects of the expression levels and decrease the power to detect links experimental conditions on the gene expressions and the with the variables of interest. nuisance variability due to unmodeled technological effects and other known or unknown effects that could be uncontrolled in the experimental design. * Correspondence: [email protected] The major sources of expression variation are then 1 Agrocampus Ouest, UMR598, Animal Genetics, 35000 Rennes, France Full list of author information is available at the end of the article assumed to be the experimental conditions of interest, © 2010 Blum et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Blum et al. BMC Bioinformatics 2010, 11:368 Page 2 of 12 http://www.biomedcentral.com/1471-2105/11/368 but also gene dependence and uncontrolled factors in the added on the first 100 gene expressions to mimic a differ- experimental design. Indeed, even after normalization, ential expression between these two groups. variation due to the experimental design still exists in Case 1: One independent variable affecting all genes expression data. The factors extracted in the residual part All genes are affected by an independent grouping vari- of the regression models explaining the gene expressions able marked by colors red and green on Figure 1A. A sin- by the experimental conditions of interest are therefore gle factor is extracted by FAMT. Figure 2A helps analyzed to give more insight both on expression hetero- interpreting this factor and shows that it clearly discrimi- geneity among sampling units and the contribution of nates the two colored groups of individuals (P-value ≤ 2.2 some biological processes to gene dependence. First, fac- × 10-16). This shows a high association between the factor tors are extracted from illustrative expression data sets and the independent grouping variable. The genes repre- with simple patterns of expression heterogeneity in order sentation does not show any particular structure. In this to show how they can straightforward be related to simple case the factor estimated by FAMT can therefore sources of heterogeneity. Henceforth, the same factor be easily interpreted through the individuals representa- model approach is used to analyze an expression data set tion. initially generated to map quantitative trait loci (QTL) for Case 2: One independent variable affecting a set of genes abdominal fatness (AF) in chickens, especially on chro- Only genes 70-170 are affected by an independent group- mosome 5 (GGA5) [5]. This data set concerns hepatic ing variable marked by colors red and green on Figure 1B. transcriptome profiles for 11213 genes of 45 half sib male A single factor is also found using FAMT. As shown on chickens generated from a same sire. This sire was gener- Figure 2B, the factor discriminates the two groups of indi- ated by successive inter-crossing of two experimental viduals (P-value ≤ 2.2 × 10-16) and the two groups of genes chicken lines divergently selected on AF and was known (P-value ≤ 2.2 × 10-16). In this case, the estimated factor to be heterozygous for an AF QTL on the GGA5 chromo- can be interpreted through the individuals and genes rep- some around 175 cM (For more details, see [5]). The 45 resentations. half sib chickens show therefore variation on AF. Accord- Case 3: Two independent variables affecting two different sets ing to the polygenic effect model of quantitative traits, of genes this variation is probably due to multiple mutations and Gene sets 70-170 and 171-271 are each affected by an biological processes. independent grouping variable marked respectively by Two lists of genes significantly correlated to the AF trait colors red and green and by colors orange and blue as are first generated using the raw and the factor-adjusted illustrated by Figure 1C. Two factors are identified by expression dataset. Then, the relevance of the two gene FAMT which are now interpreted regarding the two lists to characterize functionally fatness variation in the external sources of heterogeneity (Figure 2C). The red- family are compared, regarding the frequencies of biolog- green variable seems to be highly associated with the first ical processes related to the AF trait in their functional axis (P-value ≤ 2.2 × 10-16 in both representation). On the annotations. Factor-adjusted expression data is finally contrary, the orange-blue variable is not associated with used to identify a gene whose expression is controlled by this axis considering a significance level of 0.05 (P-value = the AF QTL region. 0.7933 for the individuals representation, p-value = Furthermore, the extracted factors are interpreted 0.1109 for the genes representation). The same strategy is using external information on the experimental design implemented for the second factor. The red-green vari- such as the hatch, dam and body weight and also gene able appears to be not associated with this factor (P-value information such as functional categories, oligonucle- = 0.7949 for the individuals representation, p-value = otide size and location on the microarray. It is deduced 0.1926 for the genes representation) whereas the orange- that some factors may have different and complex origins, blue variable is highly associated (P-value ≤ 2.2 × 10-16 in which confirms the importance of taking into account both representations). In this case, each of the two esti- these extra sources of variability to be more relevant in mated factors can be explained by one of the two inde- the transcriptomic analyses. pendent grouping variables. Results Analysis of the AF expression data set Illustrative Examples Classical approach Similarly to Storey et al (2007) [3], three simple situations Examination of the Pearson coefficient correlation of heterogeneity are considered. For each one, indepen- between hepatic transcript levels and AF trait shows that dent expressions for 1000 genes on 20 arrays are simu- 287 genes are significantly correlated considering a signif- lated according to a standard normal distribution. The icance threshold of 0.05 without any correction for multi- sample is split into two equal groups and a constant is ple tests. This low amount of differentially expressed genes might be explained by a poor genetic variability Blum et al. BMC Bioinformatics 2010, 11:368 Page 3 of 12 http://www.biomedcentral.com/1471-2105/11/368 Figure 1 Structure of the illustrative data sets. Representation of three illustrative studies consisting of 1000 genes on 20 arrays divided between two groups.
Recommended publications
  • The Title of the Article
    Mechanism-Anchored Profiling Derived from Epigenetic Networks Predicts Outcome in Acute Lymphoblastic Leukemia Xinan Yang, PhD1, Yong Huang, MD1, James L Chen, MD1, Jianming Xie, MSc2, Xiao Sun, PhD2, Yves A Lussier, MD1,3,4§ 1Center for Biomedical Informatics and Section of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, IL 60637 USA 2State Key Laboratory of Bioelectronics, Southeast University, 210096 Nanjing, P.R.China 3The University of Chicago Cancer Research Center, and The Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL 60637 USA 4The Institute for Genomics and Systems Biology, and the Computational Institute, The University of Chicago, Chicago, IL 60637 USA §Corresponding author Email addresses: XY: [email protected] YH: [email protected] JC: [email protected] JX: [email protected] XS: [email protected] YL: [email protected] - 1 - Abstract Background Current outcome predictors based on “molecular profiling” rely on gene lists selected without consideration for their molecular mechanisms. This study was designed to demonstrate that we could learn about genes related to a specific mechanism and further use this knowledge to predict outcome in patients – a paradigm shift towards accurate “mechanism-anchored profiling”. We propose a novel algorithm, PGnet, which predicts a tripartite mechanism-anchored network associated to epigenetic regulation consisting of phenotypes, genes and mechanisms. Genes termed as GEMs in this network meet all of the following criteria: (i) they are co-expressed with genes known to be involved in the biological mechanism of interest, (ii) they are also differentially expressed between distinct phenotypes relevant to the study, and (iii) as a biomodule, genes correlate with both the mechanism and the phenotype.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Instability of the Pseudoautosomal Boundary in House Mice
    Genetics: Early Online, published on April 26, 2019 as 10.1534/genetics.119.302232 Article/Investigation Instability of the pseudoautosomal boundary in house mice Andrew P Morgan∗, Timothy A Bell∗, James J Crowley∗; y; z, and Fernando Pardo-Manuel de Villena∗ ∗Department of Genetics and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC yDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC zDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden April 26, 2019 Corresponding authors: Andrew P Morgan ([email protected]) Fernando Pardo-Manuel de Villena ([email protected]) 5049C Genetic Medicine Building Department of Genetics University of North Carolina Chapel Hill NC 27599-7264 Keywords: meiosis, recombination, pseudoautosomal region, sex chromosome evolution 1 Copyright 2019. Abstract Faithful segregation of homologous chromosomes at meiosis requires pairing and recombination. In taxa with dimorphic sex chromosomes, pairing between them in the heterogametic sex is limited to a narrow inter- val of residual sequence homology known as the pseudoautosomal region (PAR). Failure to form the obligate crossover in the PAR is associated with male infertility in house mice (Mus musculus) and humans. Yet despite this apparent functional constraint, the boundary and organization of the PAR is highly variable in mammals, and even between subspecies of mice. Here we estimate the genetic map in a previously-documented ex- pansion of the PAR in the Mus musculus castaneus subspecies and show that the local recombination rate is 100-fold higher than the autosomal background. We identify an independent shift in the PAR boundary in the Mus musculus musculus subspecies and show that it involves a complex rearrangement but still recombines in heterozygous males.
    [Show full text]
  • Predicting Clinical Response to Treatment with a Soluble Tnf-Antagonist Or Tnf, Or a Tnf Receptor Agonist
    (19) TZZ _ __T (11) EP 2 192 197 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 02.06.2010 Bulletin 2010/22 C12Q 1/68 (2006.01) (21) Application number: 08170119.5 (22) Date of filing: 27.11.2008 (84) Designated Contracting States: (72) Inventor: The designation of the inventor has not AT BE BG CH CY CZ DE DK EE ES FI FR GB GR yet been filed HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (74) Representative: Habets, Winand Designated Extension States: Life Science Patents AL BA MK RS PO Box 5096 6130 PB Sittard (NL) (71) Applicant: Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg 1081 HV Amsterdam (NL) (54) Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf receptor agonist (57) The invention relates to methods for predicting a clinical response to a therapy with a soluble TNF antagonist, TNF or a TNF receptor agonist and a kit for use in said methods. EP 2 192 197 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 192 197 A1 Description [0001] The invention relates to methods for predicting a clinical response to a treatment with a soluble TNF antagonist, with TNF or a TNF receptor agonist using expression levels of genes of the Type I INF pathway and a kit for use in said 5 methods. In another aspect, the invention relates to a method for evaluating a pharmacological effect of a treatment with a soluble TNF antagonist, TNF or a TNF receptor agonist.
    [Show full text]
  • Structural and Numerical Changes of Chromosome X in Patients with Esophageal Atresia
    European Journal of Human Genetics (2014) 22, 1077–1084 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Structural and numerical changes of chromosome X in patients with esophageal atresia Erwin Brosens*,1,2,5, Elisabeth M de Jong1,2,5, Tahsin Stefan Barakat3, Bert H Eussen1, Barbara D’haene4, Elfride De Baere4, Hannah Verdin4, Pino J Poddighe1, Robert-Jan Galjaard1, Joost Gribnau3, Alice S Brooks1, Dick Tibboel2 and Annelies de Klein1 Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is a relatively common birth defect often associated with additional congenital anomalies such as vertebral, anal, cardiovascular, renal and limb defects, the so-called VACTERL association. Yet, little is known about the causal genetic factors. Rare case reports of gastrointestinal anomalies in children with triple X syndrome prompted us to survey the incidence of structural and numerical changes of chromosome X in patients with EA/TEF. All available (n ¼ 269) karyotypes of our large (321) EA/TEF patient cohort were evaluated for X-chromosome anomalies. If sufficient DNA material was available, we determined genome-wide copy number profiles with SNP array and identified subtelomeric aberrations on the difficult to profile PAR1 region using telomere-multiplex ligation-dependent probe amplification. In addition, we investigated X-chromosome inactivation (XCI) patterns and mode of inheritance of detected aberrations in selected patients. Three EA/TEF patients had an additional maternally inherited X chromosome. These three female patients had normal random XCI patterns. Two male EA/TEF patients had small inherited duplications of the XY-linked SHOX (Short stature HOmeoboX-containing) locus.
    [Show full text]
  • Analyses of PDE-Regulated Phosphoproteomes Reveal Unique and Specific Camp Signaling Modules in T Cells
    Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP signaling modules in T cells Michael-Claude G. Beltejar A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2017 Reading Committee: Joseph Beavo, Chair Shao-en Ong Richard Gardner Program Authorized to Offer Degree: Molecular and Cellular Biology ©Copyright 2017 Michael-Claude G. Beltejar University of Washington Abstract Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP signaling modules in T cells Michael-Claude G. Beltejar Chair of the Supervisory Committee: Professor Joseph A. Beavo Department of Pharmacology Specific functions for different cyclic nucleotide phosphodiesterases (PDEs) have not yet been identified in most cell types. Conventional approaches to study PDE function typically rely on measurements of global cAMP, general increases in cAMP-dependent protein kinase (PKA), or exchange protein activated by cAMP (EPAC) activity. Although newer approaches utilizing subcellularly-targeted FRET reporter sensors have helped to define more compartmentalized regulation of cAMP, PKA, and EPAC, they have limited ability to link this regulation to downstream effector molecules and biological functions. To address this problem, we used an unbiased, mass spectrometry based approach coupled with treatment using PDE isozyme- selective inhibitors to characterize the phosphoproteomes of the “functional pools” of cAMP/PKA/EPAC that are regulated by specific cAMP-PDEs (the PDE-regulated phosphoproteomes). In Jurkat cells we found multiple, distinct phosphoproteomes that differ in response to different PDE inhibitors. We also found that little phosphorylation occurs unless at least 2 different PDEs are concurrently inhibited in these cells. Moreover, bioinformatics analyses of these phosphoproteomes provides insight into the functional roles, mechanisms of action, and synergistic relationships among the different PDEs that coordinate cAMP-signaling cascades in these cells.
    [Show full text]
  • Dosage Regulation of the Active X Chromosome in Human Triploid Cells
    Dosage Regulation of the Active X Chromosome in Human Triploid Cells Xinxian Deng1, Di Kim Nguyen1, R. Scott Hansen2,3, Daniel L. Van Dyke4, Stanley M. Gartler2,3, Christine M. Disteche1,2* 1 Department of Pathology, University of Washington, Seattle, Washington, United States of America, 2 Department of Medicine, University of Washington, Seattle, Washington, United States of America, 3 Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America, 4 Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America Abstract In mammals, dosage compensation is achieved by doubling expression of X-linked genes in both sexes, together with X inactivation in females. Up-regulation of the active X chromosome may be controlled by DNA sequence–based and/or epigenetic mechanisms that double the X output potentially in response to autosomal factor(s). To determine whether X expression is adjusted depending on ploidy, we used expression arrays to compare X-linked and autosomal gene expression in human triploid cells. While the average X:autosome expression ratio was about 1 in normal diploid cells, this ratio was lower (0.81–0.84) in triploid cells with one active X and higher (1.32–1.4) in triploid cells with two active X’s. Thus, overall X- linked gene expression in triploid cells does not strictly respond to an autosomal factor, nor is it adjusted to achieve a perfect balance. The unbalanced X:autosome expression ratios that we observed could contribute to the abnormal phenotypes associated with triploidy. Absolute autosomal expression levels per gene copy were similar in triploid versus diploid cells, indicating no apparent global effect on autosomal expression.
    [Show full text]
  • Downloaded from Here
    bioRxiv preprint doi: https://doi.org/10.1101/017566; this version posted November 19, 2015. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 Testing for ancient selection using cross-population allele 2 frequency differentiation 1;∗ 3 Fernando Racimo 4 1 Department of Integrative Biology, University of California, Berkeley, CA, USA 5 ∗ E-mail: [email protected] 6 1 Abstract 7 A powerful way to detect selection in a population is by modeling local allele frequency changes in a 8 particular region of the genome under scenarios of selection and neutrality, and finding which model is 9 most compatible with the data. Chen et al. [2010] developed a composite likelihood method called XP- 10 CLR that uses an outgroup population to detect departures from neutrality which could be compatible 11 with hard or soft sweeps, at linked sites near a beneficial allele. However, this method is most sensitive 12 to recent selection and may miss selective events that happened a long time ago. To overcome this, 13 we developed an extension of XP-CLR that jointly models the behavior of a selected allele in a three- 14 population tree. Our method - called 3P-CLR - outperforms XP-CLR when testing for selection that 15 occurred before two populations split from each other, and can distinguish between those events and 16 events that occurred specifically in each of the populations after the split.
    [Show full text]
  • Identification of Shared and Unique Gene Families Associated with Oral
    International Journal of Oral Science (2017) 9, 104–109 OPEN www.nature.com/ijos ORIGINAL ARTICLE Identification of shared and unique gene families associated with oral clefts Noriko Funato and Masataka Nakamura Oral clefts, the most frequent congenital birth defects in humans, are multifactorial disorders caused by genetic and environmental factors. Epidemiological studies point to different etiologies underlying the oral cleft phenotypes, cleft lip (CL), CL and/or palate (CL/P) and cleft palate (CP). More than 350 genes have syndromic and/or nonsyndromic oral cleft associations in humans. Although genes related to genetic disorders associated with oral cleft phenotypes are known, a gap between detecting these associations and interpretation of their biological importance has remained. Here, using a gene ontology analysis approach, we grouped these candidate genes on the basis of different functional categories to gain insight into the genetic etiology of oral clefts. We identified different genetic profiles and found correlations between the functions of gene products and oral cleft phenotypes. Our results indicate inherent differences in the genetic etiologies that underlie oral cleft phenotypes and support epidemiological evidence that genes associated with CL/P are both developmentally and genetically different from CP only, incomplete CP, and submucous CP. The epidemiological differences among cleft phenotypes may reflect differences in the underlying genetic causes. Understanding the different causative etiologies of oral clefts is
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9.228,204 B2 Pulst Et Al
    USOO9228204B2 (12) United States Patent (10) Patent No.: US 9.228,204 B2 Pulst et al. (45) Date of Patent: Jan. 5, 2016 (54) CONSTRUCTS FOR MAKING INDUCED 2010, O184051 A1 7/2010 Hochedlinger et al. PLURPOTENT STEM CELLS 2010/0279.404 A1 11/2010 Yamanaka et al. 2010.0311171 A1 12/2010 Nakanishi et al. (71) Applicant: University of Utah Research Foundation, Salt Lake City, UT (US) FOREIGN PATENT DOCUMENTS EP 2263705 12/2010 (72) Inventors: Stefan M. Pulst, Salt Lake City, UT KR 2009 OO83761 8, 2009 (US); Sharan Paul, Salt Lake City, UT WO WO 2008,151058 12/2008 (US); Warunee Dansithong, Salt Lake WO WO 2009/007852 1, 2009 City, UT (US) WO WO 2009/092042 T 2009 WO WO 2009,093O22 T 2009 WO WO 2009/096614 8, 2009 (73) Assignee: University of Utah Research WO WO 2009/131262 10/2009 Foundation, Salt Lake City, UT (US) WO WO 2009,133971 11, 2009 WO WO 2009,140655 11, 2009 (*) Notice: Subject to any disclaimer, the term of this WO WO 2009, 149233 12/2009 patent is extended or adjusted under 35 WO WO 2009,152485 12/2009 U.S.C. 154(b) by 0 days. WO WO 2010/017562 2, 2010 WO WO 2010/O19569 2, 2010 WO WO 2010/028O19 3, 2010 (21) Appl. No.: 13/975,004 WO WO 2010/036923 4/2010 (22) Filed: Aug. 23, 2013 OTHER PUBLICATIONS (65) Prior Publication Data Takahashi (Cell, 2006, vol. 126:663-676).* US 2014/O 170752 A1 Jun. 19, 2014 Yu (Science, 2007, vol.
    [Show full text]
  • STAMBP Gene STAM Binding Protein
    STAMBP gene STAM binding protein Normal Function The STAMBP gene provides instructions for making a protein called STAM binding protein. Although its exact function is not well understood, within cells this protein interacts with large groups of interrelated proteins known as endosomal sorting complexes required for transport (ESCRTs). ESCRTs help transport proteins from the outer cell membrane to the interior of the cell, a process known as endocytosis. In particular, they are involved in the endocytosis of damaged or unneeded proteins that need to be broken down (degraded) or recycled by the cell. ESCRTs help sort these proteins into structures called multivesicular bodies (MVBs), which deliver them to lysosomes. Lysosomes are compartments within cells that digest and recycle many different types of molecules. Through its association with ESCRTs, STAM binding protein helps to maintain the proper balance of protein production and breakdown (protein homeostasis) that cells need to function and survive. Studies suggest that the interaction of STAM binding protein with ESCRTs is also involved in multiple chemical signaling pathways within cells, including pathways needed for overall growth and the formation of new blood vessels (angiogenesis). Health Conditions Related to Genetic Changes Microcephaly-capillary malformation syndrome At least 13 mutations in the STAMBP gene have been identified in people with microcephaly-capillary malformation syndrome, an inherited disorder characterized by an abnormally small head size (microcephaly), profound developmental delay and intellectual disability, recurrent seizures (epilepsy), and abnormalities of small blood vessels in the skin called capillaries (capillary malformations). The known STAMBP gene mutations reduce or eliminate the production of STAM binding protein.
    [Show full text]
  • Chromatin Conformation Links Distal Target Genes to CKD Loci
    BASIC RESEARCH www.jasn.org Chromatin Conformation Links Distal Target Genes to CKD Loci Maarten M. Brandt,1 Claartje A. Meddens,2,3 Laura Louzao-Martinez,4 Noortje A.M. van den Dungen,5,6 Nico R. Lansu,2,3,6 Edward E.S. Nieuwenhuis,2 Dirk J. Duncker,1 Marianne C. Verhaar,4 Jaap A. Joles,4 Michal Mokry,2,3,6 and Caroline Cheng1,4 1Experimental Cardiology, Department of Cardiology, Thoraxcenter Erasmus University Medical Center, Rotterdam, The Netherlands; and 2Department of Pediatrics, Wilhelmina Children’s Hospital, 3Regenerative Medicine Center Utrecht, Department of Pediatrics, 4Department of Nephrology and Hypertension, Division of Internal Medicine and Dermatology, 5Department of Cardiology, Division Heart and Lungs, and 6Epigenomics Facility, Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands ABSTRACT Genome-wide association studies (GWASs) have identified many genetic risk factors for CKD. However, linking common variants to genes that are causal for CKD etiology remains challenging. By adapting self-transcribing active regulatory region sequencing, we evaluated the effect of genetic variation on DNA regulatory elements (DREs). Variants in linkage with the CKD-associated single-nucleotide polymorphism rs11959928 were shown to affect DRE function, illustrating that genes regulated by DREs colocalizing with CKD-associated variation can be dysregulated and therefore, considered as CKD candidate genes. To identify target genes of these DREs, we used circular chro- mosome conformation capture (4C) sequencing on glomerular endothelial cells and renal tubular epithelial cells. Our 4C analyses revealed interactions of CKD-associated susceptibility regions with the transcriptional start sites of 304 target genes. Overlap with multiple databases confirmed that many of these target genes are involved in kidney homeostasis.
    [Show full text]